Broad experience during 22 years as entrepreneur and founder of biotech
companies. CEO of Biomedal SL, IVD company, forming multiple R&D teams,
managing, and coordinating public-private research projects. He has more
than a hundred publications and is co-inventor of fifteen patent applications.
He achieved one of the most successful operations in Spanish biotechnology
with a self-developed product that has become the world leader in its
category (Glutentox®), and several licensing agreements. Cofounder of
several high-tech companies (Biomedal, Ingeniatrics, Glutenostics).

Project Manager Professional focused on translational technologies and tech transfer projects. Scientific background in the field of genetics, genomic instability and advanced cell therapies. Ten years of experience in the private sector. She joined Abengoa Research to contribute the breakthrough projects for 2nd generation bioethanol production. She moved to Ixaka (former Rexgenero) as R&D Manager to be part of the team for the development of Phase III Clinical Trial for treating critical limb ischemia.

More than 30 years of research experience in genetics. His main research area is the genetic regulation of longevity. He has published in high impact journals in different fields. Deeply involved in technology transfer processes by developing new technologies for the industrial application. Coauthor of seven patents (3 licensed), two industrial secrets and promoter of two biotechnology companies: CEPA S.L. and Olavide Neuron STX (ONESTX). Professor at UPO.

Fifteen years of experience in research institutions such as NIH and management roles at CNIO Spain in the USA. Focused in translational research, he started to work in biotech industry as Director of PharmaGen (today Genomica SAU). Director of Innovation and Business Development at Genetrix. Jorge was Co-Director at Spherium Biomed and Biosurgery. Founder and CEO of Cellerix (later Tigenix), which after obtaining Marketing Authorization for the first ATMP on the market, was acquired in 2017 by Takeda Pharmaceuticals. CEO of OneChain Immunotherapeuics, an immuno-oncology company focused on CAR-Ts.

Ten years of academic research in Spain (CSIC, UB) and US (Roche, Mount Sinai NY). Former project management and business development in Almirall. Founder and CEO of Advancell, one of the first biotechnological spin-offs in Spain. Cofounder of ERA-Plantech (today ERA-Biotech), TCD-Pharma and Spherium Biomed, among others. Founding Partner of JANUS DEVELOPMENTS with the responsibility of transferring projects of academic origin to drug development stage for unsatisfied medical needs. In recent years, he has held executive positions in several biotech companies and helped with start companies in the academic spin-off space (Biosintaxis, Leukos Biotech, Affirma Bio). CEO at Aquilon CyL and Leukos Biotech.